Sign in
CompletedPhase 2

An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD

Key facts

Who runs it
Transcend Therapeutics
Where
Denver, Draper, and Rockville, United StatesSee the 3 sitesAlso in 2 other countries, 6 sites
Trial code
Status
Completed
Phase
Phase 2
People taking part
44 people enrolled
Started
6 Mar 2024
Ended
6 Oct 2025
Type of study
Interventional
Treatments tested
  • Methylone
Record updated
16 November 2026

Who can take part

Age
18 years to 71 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Participation in and successful completion of a prior Transcend-sponsored clinical trial with TSND-201
  • Agree to not participate in any other interventional clinical trials for the duration of this study
  • Willing and able to provide informed consent

Who cannot take part

  • Had significant deviation(s)/non-compliance in parent study in the opinion of the Investigator which would deem them unsuitable for participation
  • Change or development of any physical or psychological finding that would make participant unsuitable for study

Where in United States

Also in 2 other countries, 6 sites

  • Mountain View Clinical ResearchDenver, United States
  • Cedar Clinical Research Inc.Draper, United States
  • Sunstone MedicalRockville, United States

About the trial

What the trial wants to find out

This is an extension study of participants who previously completed a Transcend-sponsored clinical trial evaluating TSND-201 as a treatment for PTSD.

Read full original descriptionShow less

Participants will be followed for up to 52 weeks. During the 52 week period, PTSD symptoms and safety will be assessed monthly.

Participants' PTSD symptoms will be assessed at each observational visit and if criteria for Relapse has been met, participants may be eligible to receive a course of TSND-201 treatment.

The group in the trial

  • Treatment (Methylone)Treatment being tested

    Treatment: Methylone

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A 52-Week, Open-Label Evaluation of the Long-term Efficacy and Safety of Single and Repeated Treatments With Methylone for the Treatment of PTSD IMPACT-EXT (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])
Record updated
16 November 2026